Terms of Service
Effective April 21, 2026.
By using semaglutidedosage.com ("the Site") you agree to these terms. If you don't, please stop using the Site.
Not medical advice
The Site provides general educational content and reference tools based on FDA-approved prescribing information. Nothing on the Site is medical advice, diagnosis, treatment, or a prescription. Use of the Site does not create a clinician–patient relationship with us or our medical reviewer. For medical decisions, consult your own prescriber or pharmacist.
Tool accuracy
We take calculation accuracy seriously. Our units converter math is transparent and testable. However, we make no warranty that any tool, chart, or article is free of errors. You are responsible for verifying dosing before injecting. If you find an error, tell us: contact@semaglutidedosage.com.
License to use
You may view, download, and print pages for personal, non-commercial use. You may not scrape, resell, or bulk-redistribute our content. Brief quotations for educational or journalistic purposes are welcomed with attribution.
Trademarks
Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk. Their use on this Site is descriptive only. We are not affiliated with Novo Nordisk.
Links to third parties
The Site links to external sites (FDA, clinical-trial publications, advertisers). We do not control their content and are not responsible for it.
Limitation of liability
To the maximum extent permitted by law, we are not liable for any damages arising from your use of the Site, including any decision you make based on information on the Site.
Changes
We may update these terms. Material changes will be noted at the top of this page.
Governing law
These terms are governed by the laws of the United States. Any dispute will be resolved in a court of competent jurisdiction.